Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Obstetrics and Gynecology|May 1, 1990
Suppressive actions of a gonadotropin-releasing hormone antagonist on luteinizing hormone, follicle-stimulating hormone, and prolactin release in estrogen-deficient postmenopausal womenR J Urban, S N Pavlou, J E Rivier, et al.
Clinical Endocrinology|March 1, 1978
The sulpiride test in panhypopituitarismM L Batrinos, S N Pavlou, S A Pitoulis, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1987
Gonadotropins and testosterone escape from suppression during prolonged luteinizing hormone-releasing hormone antagonist administration in normal menS N Pavlou, J W Interlandi, G Wakefield, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1995
Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulationA Djerassi, C Coutifaris, V A West, et al.
Clinical Endocrinology|March 1, 1978
Assessment of prolactin release in pituitary dwarfism with the sulpiride testM L Batrinos, S N Pavlou, S A Pitoulis, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1990
Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal menS N Pavlou, J D Veldhuis, J Lindner, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1987
Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal menS N Pavlou, G B Wakefield, D P Island, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1989
Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal menS N Pavlou, G Wakefield, N L Schlechter, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1993
New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonistG A McGrath, R J Goncalves, J K Udupa, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1991
Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libidoS N Pavlou, K Brewer, M G Farley, et al.
Pageof 4